Misinformation or skewed views about the benefits or side effects can be damaging to this group for decision-making. GLP-1 RAs are not currently licensed in the UK for patients aged under 18 years but they can be prescribed off-licence to children aged 1217 years who are severely obese with other comorbidities through specialist weight-loss clinics
Contaminated peptides can introduce unknown variables into research, produce misleading results, and in the worst cases, create safety hazards for anyone handling the material
Phase 3 trials swapped out the 8 mg dose for 6 mg and 9 mg doses based on the phase 2 data
Incretin-based investigational therapies for the treatment of MASLD/MASH
Post-GLP-1, your pancreas may lag, leading to spikes (energy bursts) and crashes (fatigue or cravings) after mealsthink of that 3 p.m
The getting started with peptides guide covers universal principles that apply to any peptide, while the specific considerations below address semaglutide in particular